Congenica Tries To Bring Clarity To Personalized Medicine For Rare Diseases
Medtech Insight spoke to David Atkins, the CEO of genomics company Congenica, to learn more about how its platform is being used in one of the largest genetics studies to date. The company expects the technology to eventually transform treatment of rare diseases.
You may also be interested in...
Digital Health Roundup: A Season For Interviews, New Frontiers, AI, Cybersecurity
In this roundup feature focusing on developments in digital health, Medtech Insight highlights interviews with Medtronic, Abbott and Congenica, partnerships and launches, and AI and cybersecurity announcements from November.
Execs On The Move: April 2023
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Swedish Drug And Device To Go Head-To-Head In The GERD Space
Two Swedish companies are working on tackling GERD – one with a drug, one with a device.